Cite
Subcutaneous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy
MLA
Sander RM Bus, et al. “Subcutaneous Immunoglobulin for Chronic Inflammatory Demyelinating Polyradiculoneuropathy.” Cochrane Database of Systematic Reviews, vol. 2021, no. 10, Oct. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....62abf572d54f09b27dd6c97e6bf4d682&authtype=sso&custid=ns315887.
APA
Sander RM Bus, Luuk Wieske, Stephen Keddie, Ivo N van Schaik, & Filip Eftimov. (2021). Subcutaneous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database of Systematic Reviews, 2021(10).
Chicago
Sander RM Bus, Luuk Wieske, Stephen Keddie, Ivo N van Schaik, and Filip Eftimov. 2021. “Subcutaneous Immunoglobulin for Chronic Inflammatory Demyelinating Polyradiculoneuropathy.” Cochrane Database of Systematic Reviews 2021 (10). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....62abf572d54f09b27dd6c97e6bf4d682&authtype=sso&custid=ns315887.